NEVROLOGIK AMALIYATDA TOS A'ZALARI KASALLIKLARI BO'LGAN AYOLLARDA OG'RILIK SINDROSLARINING XUSUSIYATLARI
##article.subject##:
og'riq sindromi, yallig'lanish kasalliklari, dorsopatiya, tos a'zolari kasalliklari##article.abstract##
O'rtacha umr ko'rish davomiyligining oshishi va harakatsiz turmush tarzini olib boradigan odamlar sonining ko'payishi munosabati bilan tayanch-harakat tizimi kasalliklariga qarshi kurash choralarini ko'rish zarurati tug'ildi. Hozirgi vaqtda mushak-skelet tizimining eng keng tarqalgan kasalliklari bo'g'imlarning degenerativ va yallig'lanish kasalliklari, shuningdek osteoporozdir. [36]. Biroq, mushak-skelet tizimining kasalliklariga qo'shimcha ravishda, bel og'rig'i bilan kechadigan somatik patologiyaga katta rol berilishi kerak. Ayollarda tos a'zolari kasalliklarida og'riq sindromlari nafaqat ginekologlar, balki nevrologlar, urologlar, jarrohlar va boshqa mutaxassislar bilan hamkorlikda multitizimli yondashuvni talab qiladigan murakkab muammodir. Uzoq muddatli og'riq sindromi nafaqat jismoniy noqulaylik, balki ma'naviy noqulayliklarga olib keladi va mehnat qobiliyatini yo'qotish va oiladagi muammolarga olib keladi. Ayollarda tos a'zolari kasalliklarida og'riq sindromlarining asosiy lokalizatsiyasi tos mintaqasi va orqa qismidir.
Pelvis sohasidagi surunkali og'riqlar olti oydan ortiq davom etadi, hayz davri bilan bog'liq emas va mehnat qobiliyatini yo'qotishiga olib kelishi mumkin, shuningdek, jarrohlik yoki dori aralashuvini talab qilishi mumkin.
ICD-10 ta'rifiga ko'ra, dorsopatiyalar belning ma'lum bir sohasidagi og'riqlar va funktsional buzilishlar bilan birga bo'lgan biriktiruvchi to'qima elementlarini o'z ichiga olgan mushak-skelet tizimining lezyonlari majmuasi sifatida tushuniladi [34].
Orqa og'rig'ining hayot uchun eng xavfli sabablari o'tkir yallig'lanish kasalliklari, homiladorlikning asoratlari va birlamchi va ikkilamchi malign neoplazmalar bo'lishi mumkin [28]. Og'riq sindromlarini davolash o'ziga xos qiyinchiliklarga ega, chunki ko'pincha asosiy sabab noto'g'ri tashxis qo'yiladi va natijada patogenetik asoslangan terapiyani tanlash qiyin. Maqolada og'riq sindromi kechishining klinik xususiyatlari, diagnostika mezonlari, davolash tamoyillari, diagnostika algoritmi, shuningdek, ushbu muammolari bo'lgan bemorlarni davolash taktikasi keltirilgan.
Библиографические ссылки
Anaf V, Chapron C, El Nakadi I et al. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril 2006; 86 (5): 1336–43.
Anaf V, Simon P, El Nakadi I et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 2002; 17 (7): 1895–900.
Aziz Q, Giamberardino MA, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain. Pain. 2019 Jan;160(1):69-76. doi: 10.1097/j.pain. 0000000000001362.
Benyamin R.M. et al. // Рain Physician. 2012. V. 15. № 4. P. E363.
Berkley KJ, Dmitrieva N, Curtis KS, Papka RE. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA 2004; 101 (30): 11094–8. Epub 2004.
Berkley KJ, Rapkin AJ, Papka R.E. The pains of endometriosis. Science 2005; 308 (5728): 1587–9.
Carey TS, Garrett JM, Jackman A, Hadler N. Recurrence and care seeking after acute back pain: results of a long-term follow-up study. North Carolina Back Pain Project. Medical Care. 1999;37(2):157-164. https://doi.org/10.1097/00005650-199902000-00006
Cummins TR, Rush AM. Voltage-gated sodium channel blockers for the treatment of neuropathic pain. Expert Rev Neurother 2007; 7 (11): 1597–612.
Daniels J.P., Khan K.S. // BMJ. 2010. V. 341. P. c4834.
EAU guidelines on chronic pelvic pain 2012.
Engeler D, Baranowski AP, Borovicka J, et al. EAU guidelines on chronic pelvic pain. EAU Guidelines. EAU Annual Congress. Copenhagen; 2018. 84 p
Fall M, Baranowski AP, Fowler CJ et al. European Association of Urology. EAU guidelines on chronic pelvic pain. Eur Urol 2004; 46 (6): 681–9.
Gunter J. Chronic pelvic pain: an integrated approach to diagnosis and treatment. Obstet Gynecol Surv 2003; 58 (9): 615–23.
Hahn L. Chronic pelvic pain in women. A condition difficult to diagnose – more than 70 different diagnoses can be considered. Lakartidningen 2001; 98 (15): 1780–5.,
IASP. International Association for the study of pain «Pain terms» glossary. Pain 1986; 44–8 (Suppl. 3): 175–9.
Jarrell J.F. et al. // Obstet. Gynaecol. Can. 2005. V. 27. № 8. P. 781 17. Latthe P. et al. // BMJ. 2006. V. 332. № 7544. P. 749
Lippman S.A. et al. Uterine fibroids and gynecologic pain symptoms in a population-based study // Fertil Steril. 2003; 80: 1488. [PMID: 14667888].
Lipscomb GH, Ling FW. Chronic pelvic pain. Med Clin North Am 1995; 79 (6): 1411–25.
Lund I, Lundeberg T. Aspects of pain, its assessment and evaluation from an acupuncture perspective. Acupunct Med 2006; 24 (3): 109–
Manchikanti L. et al. // Рain Physician. 2012. V. 15. № 3. P. E199.
Million M, Wang L, Adelson DW et al. Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut 2007; 56
(10): 1482–4.
Misra SC, Pandey RM. Efficacy of drotaverine in irritable bowel syndrome: a double-blind, randomized, placebo-controlled clinical trial. Am J Gastroenterol 2000; 95: 2544 (Abs 455)
Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006; 51 (2): 240–64. Epub 2006.
Nicholas M, Vlaeyen JWS, Rief W et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019 Jan;160(1):28-37. doi: 10.1097/j.pain.0000000000001390.
Royal College of Obstetricians and Gynaecologists. The Initial Management of Chronic Pelvic Pain 2005; Guideline 41.
Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007; 10 (11): 1361–8.
Vleeming A. et al. // Eur. Spine J. 2008. V. 17. № 6. P. 794. /// Ortiz D. // Am. Fam. Physician. 2008. V. 77. № 11. P. 1535.
Wesselmann U. Clinical characteristics and pathophysiology of pelvic pain in women. Schmerz 2002; 16 (6): 467–75.
Wolsko PM, Eisenberg DM, Davis RB, Kessler R, Phillips RS. Patterns and perceptions of care for treatment of back and neck pain: results of a national survey. Spine (Phila Pa 1976). 2003;28(3):292-298. https://doi.org/10.1097/01.BRS.0000042225.88095.7C
Zondervan K.T. et al. // Br. J. Obstet. Gynaecol. 1999. V. 106. P. 1149.
Адамян Л.В., Шаров М.Н., Сонова М.М. и др. Новый взгляд на хроническую тазовую боль в гинекологической практике. Эффективная фармакотерапия. Неврология и психиатрия. 2013; 3 (32): 24–9.
Батышева Т.Т., Шварц Г.Я. Диагностика и лечение болей в спине у женщин в постменопаузальном периоде. // Лечащий врач. – 2002. - № 12.
ВОЗ. Международная статистическая классификация болезней и проблем, связанных со здоровьем. Десятый пересмотр. Том 3. Алфавитный указатель. Всемирная организация здравоохранения, 1995. Пер. с англ. М.: Медицина; 2003.
Данилов А.Б. Нейропатическая боль. М.: Нейромедиа, 2003.
Насонов Е.Л. Международная декада, посвященная костно-суставным нарушениям (The Bone and Joint Decade 2000—2010). Русский медицинский журнал. 2000;8(9):369-371.
Ниаури Д.А., Попов Э.Н., Русина Е.И. и др. Опыт применения ангиопротекторов (Гинкор-Форт) в лечении больных с синдромом хронических тазовых болей. Регионарное кровообращение и микроциркуляция. 2003; 2 (6): 32–5.
Решетняк В.К., Кукушкин М.Л. Боль: физиологические и патофизиологические аспекты. В кн.: Б.Б.Мороз (ред.). Актуальные проблемы патофизиологии (избранные лекции). М.: Медицина, 2001.
Стеняева Н. Н., Аполихина И.А. Хроническая тазовая боль: психосоматические аспекты. Consilium Medicum. 2012; 6 (14): 19–
Стрижаков А. Н., Давыдов А. И. Эндометриоз. Клинические и теоретические аспекты. М.: Медицина, 1996.
Хирургическое лечение синдрома тазовых болей в гинекологической клинике / Под ред. Г.А.Cавицкого, Р.Д.Иванова,
И.Ю.Щеглова и др. СПб.: ЭЛБИ-СПб., 2003.
Хроническая тазовая боль. Руководство для врачей. Под ред. А.Н.Белова, В.Н.Крупина. М.: Антидор, 2007.
